Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis.

Mureidomycin A (MRD), a novel peptidylnucleoside antibiotic with antipseudomonal activity, inhibited not only peptidoglycan synthesis but also lipid-intermediate formation from UDP-N-acetylmuramyl (MurNAc)-pentapeptide and UDP-N-acetylglucosamine in an in vitro peptidoglycan-synthesizing system, usi...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Isono, F, Inukai, M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1991
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC244983/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1902646/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.2.234
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!